Sarepta Therapeutics Inc
1SRPT
Company Profile
Business description
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Contact
215 First Street
Suite 415
CambridgeMA02142
USAT: +1 617 274-4000
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,372
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,770.60 | 25.40 | -0.29% |
CAC 40 | 7,684.68 | 80.43 | -1.04% |
DAX 40 | 23,516.23 | 255.22 | -1.07% |
Dow JONES (US) | 42,197.79 | 769.83 | -1.79% |
FTSE 100 | 8,850.63 | 34.29 | -0.39% |
HKSE | 23,892.56 | 142.82 | -0.59% |
NASDAQ | 19,406.83 | 255.66 | -1.30% |
Nikkei 225 | 37,834.25 | 338.84 | -0.89% |
NZX 50 Index | 12,552.87 | 96.23 | -0.76% |
S&P 500 | 5,976.97 | 68.29 | -1.13% |
S&P/ASX 200 | 8,547.40 | 17.70 | -0.21% |
SSE Composite Index | 3,377.00 | 25.66 | -0.75% |